Clinical trials
Biliary Atresia trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arbor Research Collaborative for Health | 3 |
| Albireo, an Ipsen Company | 2 |
| Intercept Pharmaceuticals | 1 |
| Mirum Pharmaceuticals, Inc. | 1 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biliary Atresia | 8 |
| Cholestasis | 2 |
| Alagille Syndrome | 1 |
| Cholangitis, Sclerosing | 1 |
| Hypertension, Portal | 1 |
| Liver Cirrhosis | 1 |
| Pruritus | 1 |
| alpha 1-Antitrypsin Deficiency | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.